Quantamental Technologies LLC Aerie Pharmaceuticals Inc Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $147,324 - $208,681	-8,314 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$18.41 - $28.0 $153,060 - $232,792	8,314 New	8,314 $160,000
Q2 2019 Aug 12, 2019	SELL	$28.97 - $48.21 $24,769 - $41,219	-855 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$36.32 - $49.25 $31,053 - $42,108	855 New	855 $41,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.